CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer

被引：11

作者：

Mehra, Niven ^{[1
,2
]}

Zafeiriou, Zafeiris ^{[1
,2
]}

Lorente, David ^{[1
,2
]}

Terstappen, Leon W. M. M. ^{[3
]}

de Bono, Johann S. ^{[1
,2
]}

机构：

[1] Inst Canc Res, Sutton SM2 5NG, Surrey, England

[2] Royal Marsden Hosp, Sutton, Surrey, England

[3] Univ Twente, Dept Med Cell BioPhys, NL-7500 AE Enschede, Netherlands

来源：

CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 22期

基金：

英国医学研究理事会;

关键词：

SURVIVAL; COUNTS; TRIAL;

D O I：

10.1158/1078-0432.CCR-14-3129

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Circulating tumor cells (CTC) have substantial promise for multipurpose biomarker studies in prostate cancer. The IMMC-38 trial conducted by de Bono and colleagues, which was published in the October 1, 2008, issue of Clinical Cancer Research, demonstrated for the first time that CTCs are the most accurate and independent predictor of overall survival in metastatic prostate cancer. Since the publication of prospective trials demonstrating prognostic utility, CTCs have been utilized for nucleic acid analyses, for protein analyses, and in intermediate endpoint studies. CTC studies are also now facilitating the analysis of intrapatient heterogeneity. (C) 2015 AACR.

引用

页码：4992 / 4995

页数：4

共 11 条

[1] Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].

Cristofanilli, M ;

Budd, GT ;

Ellis, MJ ;

Stopeck, A ;

Matera, J ;

Miller, MC ;

Reuben, JM ;

Doyle, GV ;

Allard, WJ ;

Terstappen, LWMM ;

Hayes, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791

[2] Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer [J].

Danila, Daniel C. ;

Heller, Glenn ;

Gignac, Gretchen A. ;

Gonzalez-Espinoza, Rita ;

Anand, Aseem ;

Tanaka, Erika ;

Lilja, Hans ;

Schwartz, Lawrence ;

Larson, Steven ;

Fleisher, Martin ;

Scher, Howard I. .

CLINICAL CANCER RESEARCH, 2007, 13 (23) :7053-7058

[3] Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer [J].

de Bono, Johann S. ;

Scher, Howard I. ;

Montgomery, R. Bruce ;

Parker, Christopher ;

Miller, M. Craig ;

Tissing, Henk ;

Doyle, Gerald V. ;

Terstappen, Leon W. W. M. ;

Pienta, Kenneth J. ;

Raghavan, Derek .

CLINICAL CANCER RESEARCH, 2008, 14 (19) :6302-6309

[4]

Fleisher M, 2015, J CLIN ONCOL S, V33

[5] Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer [J].

Goldkorn, Amir ;

Ely, Benjamin ;

Quinn, David I. ;

Tangen, Catherine M. ;

Fink, Louis M. ;

Xu, Tong ;

Twardowski, Przemyslaw ;

Van Veldhuizen, Peter J. ;

Agarwal, Neeraj ;

Carducci, Michael A. ;

Monk, J. Paul, III ;

Datar, Ram H. ;

Garzotto, Mark ;

Mack, Philip C. ;

Lara, Primo, Jr. ;

Higano, Celestia S. ;

Hussain, Maha ;

Thompson, Ian Murchie, Jr. ;

Cote, Richard J. ;

Vogelzang, Nicholas J. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) :1136-+

[6]

Lorente D, 2015, J CLIN ONCOL S, V33

[7] Circulating tumour cells-monitoring treatment response in prostate cancer [J].

Miyamoto, David T. ;

Sequist, Lecia V. ;

Lee, Richard J. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (07) :401-412

[8] Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience [J].

Olmos, D. ;

Arkenau, H. -T. ;

Ang, J. E. ;

Ledaki, I. ;

Attard, G. ;

Carden, C. P. ;

Reid, A. H. M. ;

A'Hern, R. ;

Fong, P. C. ;

Oomen, N. B. ;

Molife, R. ;

Dearnaley, D. ;

Parker, C. ;

Terstappen, L. W. M. M. ;

de Bono, J. S. .

ANNALS OF ONCOLOGY, 2009, 20 (01) :27-33

[9] Integrative Clinical Genomics of Advanced Prostate Cancer [J].

Robinson, Dan ;

Van Allen, Eliezer M. ;

Wu, Yi-Mi ;

Schultz, Nikolaus ;

Lonigro, Robert J. ;

Mosquera, Juan-Miguel ;

Montgomery, Bruce ;

Taplin, Mary-Ellen ;

Pritchard, Colin C. ;

Attard, Gerhardt ;

Beltran, Himisha ;

Abida, Wassim ;

Bradley, Robert K. ;

Vinson, Jake ;

Cao, Xuhong ;

Vats, Pankaj ;

Kunju, Lakshmi P. ;

Hussain, Maha ;

Feng, Felix Y. ;

Tomlins, Scott A. ;

Cooney, Kathleen A. ;

Smith, David C. ;

Brennan, Christine ;

Siddiqui, Javed ;

Mehra, Rohit ;

Chen, Yu ;

Rathkopf, Dana E. ;

Morris, Michael J. ;

Solomon, Stephen B. ;

Durack, Jeremy C. ;

Reuter, Victor E. ;

Gopalan, Anuradha ;

Gao, Jianjiong ;

Loda, Massimo ;

Lis, Rosina T. ;

Bowden, Michaela ;

Balk, Stephen P. ;

Gaviola, Glenn ;

Sougnez, Carrie ;

Gupta, Manaswi ;

Yu, Evan Y. ;

Mostaghel, Elahe A. ;

Cheng, Heather H. ;

Mulcahy, Hyojeong ;

True, Lawrence D. ;

Plymate, Stephen R. ;

Dvinge, Heidi ;

Ferraldeschi, Roberta ;

Flohr, Penny ;

Miranda, Susana .

CELL, 2015, 161 (05) :1215-1228

[10] Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer [J].

Scher, Howard I. ;

Heller, Glenn ;

Molina, Arturo ;

Attard, Gerhardt ;

Danila, Daniel C. ;

Jia, Xiaoyu ;

Peng, Weimin ;

Sandhu, Shahneen K. ;

Olmos, David ;

Riisnaes, Ruth ;

McCormack, Robert ;

Burzykowski, Tomasz ;

Kheoh, Thian ;

Fleisher, Martin ;

Buyse, Marc ;

de Bono, Johann S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) :1348-+

← 1 2 →